FRESENIUS SE & CO KGAA (FRE.DE) Stock Fundamental Analysis
FRA:FRE - Deutsche Boerse Ag - DE0005785604 - Common Stock - Currency: EUR
Overall FRE gets a fundamental rating of 3 out of 10. We evaluated FRE against 24 industry peers in the Health Care Providers & Services industry. FRE scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. FRE has a valuation in line with the averages, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year FRE was profitable.
In the past year FRE had a positive cash flow from operations.
Of the past 5 years FRE 4 years were profitable.
Each year in the past 5 years FRE had a positive operating cash flow.
1.2 Ratios
The Return On Assets of FRE (-0.90%) is worse than 78.26% of its industry peers.
FRE has a worse Return On Equity (-2.03%) than 73.91% of its industry peers.
FRE's Return On Invested Capital of 2.32% is on the low side compared to the rest of the industry. FRE is outperformed by 69.57% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.9% | ||
| ROE | -2.03% | ||
| ROIC | 2.32% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
FRE has a Operating Margin (6.59%) which is in line with its industry peers.
FRE's Operating Margin has declined in the last couple of years.
FRE has a Gross Margin of 24.04%. This is comparable to the rest of the industry: FRE outperforms 47.83% of its industry peers.
In the last couple of years the Gross Margin of FRE has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.59% | ||
| PM (TTM) | N/A | ||
| GM | 24.04% |
OM growth 3Y-23.59%
OM growth 5Y-16.57%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.26%
GM growth 5Y-5.01%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), FRE is destroying value.
There is no outstanding debt for FRE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
FRE has an Altman-Z score of 1.85. This is not the best score and indicates that FRE is in the grey zone with still only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 1.85, FRE is doing good in the industry, outperforming 60.87% of the companies in the same industry.
FRE has a debt to FCF ratio of 6.24. This is a slightly negative value and a sign of low solvency as FRE would need 6.24 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 6.24, FRE is doing good in the industry, outperforming 65.22% of the companies in the same industry.
A Debt/Equity ratio of 0.61 indicates that FRE is somewhat dependend on debt financing.
The Debt to Equity ratio of FRE (0.61) is better than 78.26% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.61 | ||
| Debt/FCF | 6.24 | ||
| Altman-Z | 1.85 |
ROIC/WACC0.47
WACC4.9%
2.3 Liquidity
A Current Ratio of 1.36 indicates that FRE should not have too much problems paying its short term obligations.
The Current ratio of FRE (1.36) is better than 78.26% of its industry peers.
A Quick Ratio of 1.05 indicates that FRE should not have too much problems paying its short term obligations.
FRE has a better Quick ratio (1.05) than 78.26% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.36 | ||
| Quick Ratio | 1.05 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 30.12% over the past year.
Looking at the last year, FRE shows a very negative growth in Revenue. The Revenue has decreased by -41.63% in the last year.
FRE shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -7.83% yearly.
EPS 1Y (TTM)30.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%195.83%
Revenue 1Y (TTM)-41.63%
Revenue growth 3Y-14.97%
Revenue growth 5Y-7.83%
Sales Q2Q%-2.75%
3.2 Future
FRE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 59.85% yearly.
FRE is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -1.58% yearly.
EPS Next Y655.38%
EPS Next 2Y186.98%
EPS Next 3Y107.95%
EPS Next 5Y59.85%
Revenue Next Year-22.33%
Revenue Next 2Y-9.7%
Revenue Next 3Y-5.1%
Revenue Next 5Y-1.58%
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 36.05 indicates a quite expensive valuation of FRE.
Based on the Price/Earnings ratio, FRE is valued a bit more expensive than 65.22% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 29.43. FRE is valued slightly more expensive when compared to this.
With a Price/Forward Earnings ratio of 11.78, the valuation of FRE can be described as very reasonable.
69.57% of the companies in the same industry are more expensive than FRE, based on the Price/Forward Earnings ratio.
FRE's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.65.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 36.05 | ||
| Fwd PE | 11.78 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of FRE is on the same level as its industry peers.
FRE's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 10.28 | ||
| EV/EBITDA | 10.07 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
FRE's earnings are expected to grow with 107.95% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.06
PEG (5Y)N/A
EPS Next 2Y186.98%
EPS Next 3Y107.95%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 3.29%, FRE has a reasonable but not impressive dividend return.
FRE's Dividend Yield is rather good when compared to the industry average which is at 2.95. FRE pays more dividend than 82.61% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.27, FRE pays a bit more dividend than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.29% |
5.2 History
The dividend of FRE decreases each year by -1.10%.
Dividend Growth(5Y)-1.1%
Div Incr Years0
Div Non Decr Years2
5.3 Sustainability
FRE has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-1.57%
EPS Next 2Y186.98%
EPS Next 3Y107.95%
FRA:FRE (2/26/2025, 5:35:30 PM)
38.93
+2.37 (+6.48%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners42.21%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap21.93B
Analysts83.33
Price Target42.21 (8.43%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.29% |
Yearly Dividend1.59
Dividend Growth(5Y)-1.1%
DP-1.57%
Div Incr Years0
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.74%
Min EPS beat(2)-3.48%
Max EPS beat(2)8.96%
EPS beat(4)1
Avg EPS beat(4)-63.95%
Min EPS beat(4)-255.06%
Max EPS beat(4)8.96%
EPS beat(8)3
Avg EPS beat(8)-65.75%
EPS beat(12)4
Avg EPS beat(12)-45.77%
EPS beat(16)6
Avg EPS beat(16)-34.17%
Revenue beat(2)1
Avg Revenue beat(2)-0.63%
Min Revenue beat(2)-1.67%
Max Revenue beat(2)0.41%
Revenue beat(4)1
Avg Revenue beat(4)-1.02%
Min Revenue beat(4)-1.67%
Max Revenue beat(4)0.41%
Revenue beat(8)1
Avg Revenue beat(8)-1%
Revenue beat(12)3
Avg Revenue beat(12)-0.51%
Revenue beat(16)5
Avg Revenue beat(16)-0.32%
PT rev (1m)5%
PT rev (3m)7.08%
EPS NQ rev (1m)6.7%
EPS NQ rev (3m)-2.59%
EPS NY rev (1m)2.36%
EPS NY rev (3m)2.36%
Revenue NQ rev (1m)-0.18%
Revenue NQ rev (3m)-1.04%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.67%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 36.05 | ||
| Fwd PE | 11.78 | ||
| P/S | 1 | ||
| P/FCF | 10.28 | ||
| P/OCF | 7.07 | ||
| P/B | 1.16 | ||
| P/tB | 12.75 | ||
| EV/EBITDA | 10.07 |
EPS(TTM)1.08
EY2.77%
EPS(NY)3.31
Fwd EY8.49%
FCF(TTM)3.79
FCFY9.73%
OCF(TTM)5.5
OCFY14.14%
SpS38.85
BVpS33.43
TBVpS3.05
PEG (NY)0.06
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.9% | ||
| ROE | -2.03% | ||
| ROCE | 4.23% | ||
| ROIC | 2.32% | ||
| ROICexc | 2.54% | ||
| ROICexgc | 5.64% | ||
| OM | 6.59% | ||
| PM (TTM) | N/A | ||
| GM | 24.04% | ||
| FCFM | 9.75% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-23.59%
OM growth 5Y-16.57%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.26%
GM growth 5Y-5.01%
F-Score3
Asset Turnover0.52
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.61 | ||
| Debt/FCF | 6.24 | ||
| Debt/EBITDA | 3.91 | ||
| Cap/Depr | 64.86% | ||
| Cap/Sales | 4.42% | ||
| Interest Coverage | 3.35 | ||
| Cash Conversion | 105.66% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.36 | ||
| Quick Ratio | 1.05 | ||
| Altman-Z | 1.85 |
F-Score3
WACC4.9%
ROIC/WACC0.47
Cap/Depr(3y)72.65%
Cap/Depr(5y)81.71%
Cap/Sales(3y)6.48%
Cap/Sales(5y)6.6%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)30.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%195.83%
EPS Next Y655.38%
EPS Next 2Y186.98%
EPS Next 3Y107.95%
EPS Next 5Y59.85%
Revenue 1Y (TTM)-41.63%
Revenue growth 3Y-14.97%
Revenue growth 5Y-7.83%
Sales Q2Q%-2.75%
Revenue Next Year-22.33%
Revenue Next 2Y-9.7%
Revenue Next 3Y-5.1%
Revenue Next 5Y-1.58%
EBIT growth 1Y-43.28%
EBIT growth 3Y-35.03%
EBIT growth 5Y-23.11%
EBIT Next Year36.04%
EBIT Next 3Y17.39%
EBIT Next 5Y12.11%
FCF growth 1Y-5.62%
FCF growth 3Y-7.43%
FCF growth 5Y15.58%
OCF growth 1Y-24.81%
OCF growth 3Y-12.28%
OCF growth 5Y3.39%